Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
2
40%
Ph phase_3
2
40%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 32 (40.0%)
N/A2 (40.0%)

Trials by Status

recruiting120%
completed240%
unknown240%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_3

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

NCT06319820
completedphase_1

Use of Ranibizumab With Mitomycin C During Trabeculectomy

NCT00661583
unknownnot_applicable

Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium

NCT02102776
completednot_applicable

Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane

NCT01319721
unknownphase_3

Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method

NCT02385370

Clinical Trials (5)

Showing 5 of 5 trials
NCT06319820Phase 3

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting
NCT00661583Phase 1

Use of Ranibizumab With Mitomycin C During Trabeculectomy

Completed
NCT02102776Not Applicable

Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium

Unknown
NCT01319721Not Applicable

Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane

Completed
NCT02385370Phase 3

Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5